IL-2 conjugates and methods of use thereof
US11077195B2 · kind B2 · utility
6Cited by
226References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2020 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Jul 1, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions, kits, and methods comprising interleukin (IL) conjugates (e.g., IL-2 conjugates) useful for the treatment of one or more indications. Also described herein are pharmaceutical compositions and kits comprising one or more of the interleukin conjugates (e.g., IL-2 conjugates).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.